Fact CheckerSign in

NCT07880054Completed

Sleep Quality and Frailty Among People Living With HIV

Effects of Sleep Quality on Frailty Among People Living With HIV: A Case-Control Study

Source: ClinicalTrials.gov · Last updated 19 Oct 2026

Brief summary (registry, in English)

With effective antiretroviral therapy (ART), people living with HIV (PLWH) are living longer and are increasingly experiencing aging-related conditions such as frailty and sleep problems. However, most frailty research has focused on the general older population, and little is known about how sleep relates to physical and oral frailty in PLWH. This case-control study compares sleep disturbance, physical frailty, and oral hypofunction between adults living with HIV receiving ART and sex-matched HIV-negative pre-exposure prophylaxis (PrEP) users recruited from an infectious disease outpatient clinic at a medical center in southern Taiwan. The study also examines whether sleep disturbance (insomnia severity and daytime sleepiness) is associated with physical frailty and oral hypofunction, whether physical frailty represents an indirect pathway between sleep disturbance and oral hypofunction, and the roles of ART and serum Galectin-3 levels in predicting frailty among PLWH.

Status (registry)
Completed
Study type
Observational
Enrollment
130 (actual)
First submitted
11 Oct 2026
Start date
25 Feb 2025
Primary completion date
29 Apr 2026
Lead sponsor
National Sun Yat-sen University
Diseases
HIV
NCT number
NCT07880054

What you commit to

  • Study type: Observational
  • Participants enrolled: 130
  • From 25 Feb 2025 to the primary completion date, 29 Apr 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Unstable medical condition

Other

  • Pregnancy

Who the study is looking for

  • Case group (PLWH):
  • Aged 20 years or older
  • Diagnosed with HIV infection
  • Receiving antiretroviral therapy (ART) for at least 3 months
    • Control group:
  • Aged 20 years or older
  • HIV-negative (e.g., pre-exposure prophylaxis \[PrEP\] users followed at the same clinic)

Age in the registry: 20 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
National Cheng Kung University Hospital
Coordinator of this site? Confirm its status
TainanTaiwanUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.